1.            Michaeli, T. F. et al. Hepatocyte regeneration is driven by embryo-like DNA methylation reprogramming. Proc. Natl. Acad. Sci. U. S. A. 121, (2024).

2.            Yehezkel, A. S. et al. AN1284 attenuates steatosis, lipogenesis, and fibrosis in mice with pre-existing non-alcoholic steatohepatitis and directly affects aryl hydrocarbon receptor in a hepatic cell line. Front. Endocrinol. (Lausanne). 14, (2023).

3.            Dahan, T. et al. Chronic Intermittent Hypoxia during Sleep Causes Browning of Interscapular Adipose Tissue Accompanied by Local Insulin Resistance in Mice. Int. J. Mol. Sci. 23, (2022).

4.            Hinden, L. et al. Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function. Nat. Commun. 13, (2022).

5.            Abudi, N. et al. Premature Macrophage Activation by Stored Red Blood Cell Transfusion Halts Liver Regeneration Post-Partial Hepatectomy in Rats. Cells 11, (2022).

6.            Shriki, A. et al. Multiple roles of il6 in hepatic injury, steatosis, and senescence aggregate to suppress tumorigenesis. Cancer Res. 81, 4766–4777 (2021).

7.            Grunewald, M. et al. Counteracting age-related VEGF signaling insufficiency promotes healthy aging and extends life span. Science 373, (2021).

8.            Ginosar, Y. et al. Chronic hypoxia in pregnant mice impairs the placental and fetal vascular response to acute hypercapnia in BOLD-MRI hemodynamic response imaging. Placenta 110, 29–38 (2021).

9.            Shapiro, J. et al. BOLD-MRI demonstrates acute placental and fetal organ hypoperfusion with fetal brain sparing in response to phenylephrine but not ephedrine. Placenta 90, 52–57 (2020).

10.          Klein, S. et al. CXCR4 promotes neuroblastoma growth and therapeutic resistance through miR-15a/ 16-1–mediated ERK and BCL2/Cyclin D1 pathways. Cancer Res. 78, 1471–1483 (2018).

11.          Ginosar, Y. et al. BOLD-MRI demonstrates acute placental and fetal organ hypoperfusion with fetal brain sparing during hypercapnia. Placenta 63, 53–60 (2018).

12.          Lanton, T. et al. Interleukin 6–dependent genomic instability heralds accelerated carcinogenesis following liver regeneration on a background of chronic hepatitis. Hepatology 65, 1600–1611 (2017).

13.          Fähling, M. et al. Cyclosporin a induces renal episodic hypoxia. Acta Physiol. 219, 625–639 (2017).

14.          Matot, I. et al. Impaired liver regeneration after hepatectomy and bleeding is associated with a shift from hepatocyte proliferation to hypertrophy. FASEB J. 31, 5283–5295 (2017).

15.          Ginosar, Y., Nachmanson, N. C., Shapiro, J., Weissman, C. & Abramovitch, R. Inhaled carbon dioxide causes dose-dependent paradoxical bradypnea in animals anesthetized with pentobarbital, but not with isoflurane or ketamine. Respir. Physiol. Neurobiol. 217, 1–7 (2015).

16.          Hijazi, N. et al. Endogenous plasminogen activators mediate progressive intracerebral hemorrhage after traumatic brain injury in mice. Blood 125, 2558–2567 (2015).

17.          Zeira, E. et al. The knockdown of H19lncRNA reveals its regulatory role in pluripotency and tumorigenesis of human embryonic carcinoma cells. Oncotarget 6, 34691–34703 (2015).

18.          Tempel-Brami, C. et al. Practical Applications of in Vivo and ex Vivo MRI in Toxicologic Pathology Using a Novel High-performance Compact MRI System. Toxicol. Pathol. 43, 633–650 (2015).

19.          Laufer, H. et al. Monitoring brain tumor vascular heamodynamic following anti-angiogenic therapy with advanced magnetic resonance imaging in mice. PLoS One 9, (2014).

20.          Komar-Stossel, C. et al. TL-118 and gemcitabine drug combination display therapeutic efficacy in a mycn amplified orthotopic neuroblastoma murine model - Evaluation by MRI. PLoS One 9, (2014).

21.          Ella, E. et al. Specific genomic and transcriptomic aberrations in tumors induced by partial hepatectomy of a chronically inflamed murine liver. Oncotarget 5, 10318–10331 (2014).

22.          Edrei, Y. et al. Quantitative functional MRI biomarkers improved early detection of colorectal liver metastases. J. Magn. Reson. Imaging 39, 1246–1253 (2014).

23.          Milman, Z., Axelrod, J. H., Heyman, S. N., Nachmansson, N. & Abramovitch, R. Assessment with unenhanced MRI techniques of renal morphology and hemodynamic changes during acute kidney injury and chronic kidney disease in mice. Am. J. Nephrol. 39, 268–278 (2014).

24.          Khvalevsky, E. Z. et al. Mutant KRAS is a druggable target for pancreatic cancer. Proc. Natl. Acad. Sci. U. S. A. 110, 20723–20728 (2013).

25.          Barashi, N. et al. Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice. Hepatology 58, 1021–1030 (2013).

26.          Artzi, M., Aizenstein, O., Abramovitch, R. & Bashat, D. B. MRI multiparametric hemodynamic characterization of the normal brain. Neuroscience 240, 269–276 (2013).

27.          Milman, Z. et al. Hemodynamic response magnetic resonance imaging: Application for renal hemodynamic characterization. Nephrol. Dial. Transplant. 28, 1150–1156 (2013).

28.          Matot, I. et al. Resuscitation with aged blood exacerbates liver injury in a hemorrhagic rat model. Crit. Care Med. 41, 842–849 (2013).

29.          Ben Bashat, D. et al. Hemodynamic Response Imaging: A Potential Tool for the Assessment of Angiogenesis in Brain Tumors. PLoS One 7, (2012).

30.          Edrei, Y., Gross, E., Corchia, N. & Abramovitch, R. Improved efficacy of a novel anti-angiogenic drug combination (TL-118) against colorectal-cancer liver metastases; MRI monitoring in mice. Br. J. Cancer 107, 658–666 (2012).

31.          Sela, Y. et al. FMRI-based hierarchical SVM model for the classification and grading of liver fibrosis. IEEE Trans. Biomed. Eng. 58, 2574–2581 (2011).

32.          Edrei, Y. et al. Vascular profile characterization of liver tumors by magnetic resonance imaging using hemodynamic response imaging in mice. Neoplasia 13, 244–253 (2011).

33.          Cohen, I. et al. Etk/Bmx regulates proteinase-activated-receptor1 (PAR1) in breast cancer invasion: Signaling partners, hierarchy and physiological significance. PLoS One 5, (2010).

34.          Gielchinsky, Y. et al. Pregnancy restores the regenerative capacity of the aged liver via activation of an mTORC1-controlled hyperplasia/hypertrophy switch. Genes Dev. 24, 543–548 (2010).

35.          Barash, H. et al. Accelerated carcinogenesis following liver regeneration is associated with chronic inflammation-induced double-strand DNA breaks. Proc. Natl. Acad. Sci. U. S. A. 107, 2207–2212 (2010).

36.          Freiman, M. et al. Multi-class SVM model for fMRI-based classification and grading of liver fibrosis. in Medical Imaging 2010: Computer-Aided Diagnosis (eds. R.M., S. & N., K.) vol. 7624 (SPIE, 2010).

37.          Zorde-Khvalevsky, E. et al. Toll-like receptor 3 signaling attenuates liver regeneration. Hepatology 50, 198–206 (2009).

38.          Beider, K. et al. Interaction between CXCR4 and CCL20 pathways regulates tumor growth. PLoS One 4, (2009).

39.          Freiman, M. et al. Classification of suspected liver metastases using fMRI images: A machine learning approach. 11th International Conference on Medical Image Computing and Computer-Assisted Intervention, MICCAI 2008 vol. 5241 LNCS 93–100 (2008).

40.          Barash, H. et al. Functional magnetic resonance imaging monitoring of pathological changes in rodent livers during hyperoxia and hypercapnia. Hepatology 48, 1232–1241 (2008).

41.          Freiman, M., Edrei, Y., Gross, E., Joskowicz, L. & Abramovitch, R. Liver metastasis early detection using fMRI based statistical model. in 2008 5th IEEE International Symposium on Biomedical Imaging: From Nano to Macro, ISBI 584–587 (2008). doi:10.1109/ISBI.2008.4541063.

42.          Meyuhas, R. et al. A key role for cyclic AMP-responsive element binding protein in hypoxia-mediated activation of the angiogenesis factor CCN1(CYR61) in tumor cells. Mol. Cancer Res. 6, 1397–1409 (2008).

43.          Ben Moshe, T. et al. Cell-autonomous and non-cell-autonomous functions of caspase-8. Cytokine Growth Factor Rev. 19, 209–217 (2008).

44.          Matot, I. et al. Lung injury after in vivo reperfusion: Outcome at 27 hours after reperfusion. Anesthesiology 109, 269–278 (2008).

45.          Matot, I., Cohen, K., Pappo, O., Barash, H. & Abramovitch, R. Liver response to hemorrhagic shock and subsequent resuscitation: MRI analysis. Shock 29, 16–24 (2008).

46.          Barash, H. et al. Functional MR imaging during hypercapnia and hyperoxia: Noninvasive tool for monitoring changes in liver perfusion and hemodynamics in a rat model. Radiology 243, 727–735 (2007).

47.          Ben Moshe, T. et al. Role of caspase-8 in hepatocyte response to infection and injury in mice. Hepatology 45, 1014–1024 (2007).

48.          Gafni, Y. et al. Design of a filamentous polymeric scaffold for in vivo guided angiogenesis. Tissue Eng. 12, 3021–3034 (2006).

49.          Grunewald, M. et al. VEGF-Induced Adult Neovascularization: Recruitment, Retention, and Role of Accessory Cells (DOI:10.1016/j.cell.2005.10.036). Cell 126, 811 (2006).

50.          Cohen, I. et al. Heparanase promotes growth, angiogenesis and survival of primary breast tumors. Int. J. Cancer 118, 1609–1617 (2006).

51.          Grunewald, M. et al. VEGF-induced adult neovascularization: Recruitment, retention, and role of accessory cells. Cell 124, 175–189 (2006).

52.          Zcharia, E. et al. Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models. FASEB J. 19, 211–221 (2005).

53.          Pikarsky, E. et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431, 461–466 (2004).

54.          Darash-Yahana, M. et al. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J. 18, 1240–1242 (2004).

55.          Shabat, S. et al. Osteonecrosis in a Chemically Induced Rat Model of Human Hemolytic Disorders Associated with Thrombosis - A New Model for Avascular Necrosis of Bone. Calcif. Tissue Int. 74, 220–228 (2004).

56.          Abramovitch, R. et al. A Pivotal Role of Cyclic AMP-Responsive Element Binding Protein in Tumor Progression. Cancer Res. 64, 1338–1346 (2004).

57.          Abramovitch, R. et al. Halofuginone inhibits angiogenesis and growth in implanted metastatic rat brain tumor model - An MRI study. Neoplasia 6, 480–489 (2004).

58.          Goldshmidt, O. et al. Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis. Proc. Natl. Acad. Sci. U. S. A. 99, 10031–10036 (2002).

59.          Dor, Y. et al. Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J. 21, 1939–1947 (2002).

60.          Shaharabany, M. et al. In vivo molecular imaging of met tyrosine kinase growth factor receptor activity in normal organs and breast tumors. Cancer Res. 61, 4873–4878 (2001).

61.          Gross, D. J. et al. The antiangiogenic agent linomide inhibits the growth rate of von Hippel-Lindau paraganglioma xenografts to mice. Clin. Cancer Res. 5, 3669–3675 (1999).

62.          Abramovitch, R., Dafni, H., Smouha, E., Benjamin, L. E. & Neeman, M. In vivo prediction of vascular susceptibility to vascular endothelial growth factor withdrawal: Magnetic resonance imaging of C6 rat glioma in nude mice. Cancer Res. 59, 5012–5016 (1999).

63.          Abramovitch, R., Dafni, H., Neeman, M., Nagler, A. & Pines, M. Inhibition of Neovascularization and Tumor Growth, and Facilitation of Wound Repair, by Halofuginone, an Inhibitor of Collagen Type I Synthesis. Neoplasia 1, 321–329 (1999).

64.          Abramovitch, R., Marikovsky, M., Meir, G. & Neeman, M. Stimulation of tumour growth by wound-derived growth factors. Br. J. Cancer 79, 1392–1398 (1999).

65.          Carmeliet, P. et al. Erratum: Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis (Nature (1998) 394 (485-490)). Nature 395, 525 (1998).

66.          Carmeliet, P. et al. Role of HIF-1α in hypoxiamediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485–490 (1998).

67.          Abramovitch, R. et al. Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor. FEBS Lett. 425, 441–447 (1998).

68.          Abramovitch, R., Frenkiel, D. & Neeman, M. Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging. Magn. Reson. Med. 39, 813–824 (1998).

69.          Abramovitch, R., Marikovsky, M., Meir, G. & Neeman, M. Stimulation of tumour angiogenesis by proximal wounds: Spatial and temporal analysis by MRI. Br. J. Cancer 77, 440–447 (1998).

70.          Schiffenbauer, Y. S. et al. Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. Proc. Natl. Acad. Sci. U. S. A. 94, 13203–13208 (1997).

71.          Neeman, M., Abramovitch, R., Schiffenbauer, Y. S. & Tempel, C. Regulation of angiogenesis by hypoxic stress: From solid tumours to the ovarian follicle. Int. J. Exp. Pathol. 78, 57–70 (1997).

72.          Abramovitch, R., Meir, G. & Neeman, M. Neovascularization Induced Growth of Implanted C6 Glioma Multicellular Spheroids: Magnetic Resonance Microimaging. Cancer Res. 55, 1956–1962 (1995).

73.          Schiffenbauer, Y. S., Tempel, C., Abramovitch, R., Meir, G. & Neeman, M. Cyclocreatine Accumulation Leads to Cellular Swelling in C6 Glioma Multicellular Spheroids: Diffusion and One-Dimensional Chemical Shift Nuclear Magnetic Resonance Microscopy. Cancer Res. 55, 153–158 (1995).